摘要：

FIELD: medicine, pharmacology, biochemistry, pharmacy. SUBSTANCE: invention relates to a pharmaceutical composition that comprises a medicine orlistat and sucrose fatty acid ester wherein fatty acid moiety in fatty acid di-, tri- or tetra-ester means a mixture of two or some fatty acids. Also, invention relates to a method for treatment of obesity by using the claimed composition. Invention provides enhancing effectiveness of treatment. EFFECT: enhanced and valuable properties of composition. 36 cl, 5 dwg, 7 tbl, 19 ex

展开